vs

Side-by-side financial comparison of CENTRUS ENERGY CORP (LEU) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

CENTRUS ENERGY CORP is the larger business by last-quarter revenue ($146.2M vs $87.2M, roughly 1.7× Schrodinger, Inc.). On growth, Schrodinger, Inc. posted the faster year-over-year revenue change (-1.2% vs -3.6%). Schrodinger, Inc. produced more free cash flow last quarter ($-16.1M vs $-58.0M). Over the past eight quarters, CENTRUS ENERGY CORP's revenue compounded faster (82.9% CAGR vs 54.4%).

Centrus Energy Corp. is an American company that supplies nuclear fuel for use in nuclear power plants and works to develop and deploy centrifuge technology to produce enriched uranium for commercial and government uses, including for national security.

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

LEU vs SDGR — Head-to-Head

Bigger by revenue
LEU
LEU
1.7× larger
LEU
$146.2M
$87.2M
SDGR
Growing faster (revenue YoY)
SDGR
SDGR
+2.3% gap
SDGR
-1.2%
-3.6%
LEU
More free cash flow
SDGR
SDGR
$41.9M more FCF
SDGR
$-16.1M
$-58.0M
LEU
Faster 2-yr revenue CAGR
LEU
LEU
Annualised
LEU
82.9%
54.4%
SDGR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LEU
LEU
SDGR
SDGR
Revenue
$146.2M
$87.2M
Net Profit
$32.5M
Gross Margin
23.9%
65.7%
Operating Margin
8.8%
-19.7%
Net Margin
37.3%
Revenue YoY
-3.6%
-1.2%
Net Profit YoY
180.8%
EPS (diluted)
$0.52
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LEU
LEU
SDGR
SDGR
Q4 25
$146.2M
$87.2M
Q3 25
$74.9M
$54.3M
Q2 25
$154.5M
$54.8M
Q1 25
$73.1M
$59.6M
Q4 24
$151.6M
$88.3M
Q3 24
$57.7M
$35.3M
Q2 24
$189.0M
$47.3M
Q1 24
$43.7M
$36.6M
Net Profit
LEU
LEU
SDGR
SDGR
Q4 25
$32.5M
Q3 25
$3.9M
$-32.8M
Q2 25
$28.9M
$-43.2M
Q1 25
$27.2M
$-59.8M
Q4 24
$-40.2M
Q3 24
$-5.0M
$-38.1M
Q2 24
$30.6M
$-54.0M
Q1 24
$-6.1M
$-54.7M
Gross Margin
LEU
LEU
SDGR
SDGR
Q4 25
23.9%
65.7%
Q3 25
-5.7%
51.6%
Q2 25
34.9%
47.8%
Q1 25
45.0%
52.3%
Q4 24
40.8%
72.6%
Q3 24
15.4%
50.2%
Q2 24
19.3%
66.2%
Q1 24
9.8%
51.6%
Operating Margin
LEU
LEU
SDGR
SDGR
Q4 25
8.8%
-19.7%
Q3 25
-22.2%
-84.6%
Q2 25
21.7%
-96.6%
Q1 25
28.0%
-85.5%
Q4 24
29.7%
-23.5%
Q3 24
-13.2%
-193.9%
Q2 24
11.2%
-111.4%
Q1 24
-24.3%
-184.3%
Net Margin
LEU
LEU
SDGR
SDGR
Q4 25
37.3%
Q3 25
5.2%
-60.4%
Q2 25
18.7%
-78.8%
Q1 25
37.2%
-100.4%
Q4 24
-45.5%
Q3 24
-8.7%
-108.1%
Q2 24
16.2%
-114.2%
Q1 24
-14.0%
-149.5%
EPS (diluted)
LEU
LEU
SDGR
SDGR
Q4 25
$0.52
$0.45
Q3 25
$0.19
$-0.45
Q2 25
$1.59
$-0.59
Q1 25
$1.60
$-0.82
Q4 24
$3.26
$-0.55
Q3 24
$-0.30
$-0.52
Q2 24
$1.89
$-0.74
Q1 24
$-0.38
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LEU
LEU
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$2.0B
$395.5M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$765.1M
$364.1M
Total Assets
$2.4B
$726.2M
Debt / EquityLower = less leverage
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LEU
LEU
SDGR
SDGR
Q4 25
$2.0B
$395.5M
Q3 25
$1.6B
$391.2M
Q2 25
$833.0M
$450.2M
Q1 25
$653.0M
$500.3M
Q4 24
$671.4M
$352.1M
Q3 24
$194.3M
$388.7M
Q2 24
$227.0M
$377.3M
Q1 24
$209.3M
$431.1M
Total Debt
LEU
LEU
SDGR
SDGR
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$390.0M
Q1 25
$389.5M
Q4 24
$472.5M
Q3 24
$83.5M
Q2 24
$86.5M
Q1 24
$86.5M
Stockholders' Equity
LEU
LEU
SDGR
SDGR
Q4 25
$765.1M
$364.1M
Q3 25
$363.1M
$321.4M
Q2 25
$359.1M
$342.9M
Q1 25
$213.9M
$373.5M
Q4 24
$161.4M
$421.4M
Q3 24
$76.4M
$449.4M
Q2 24
$76.6M
$474.0M
Q1 24
$33.8M
$513.7M
Total Assets
LEU
LEU
SDGR
SDGR
Q4 25
$2.4B
$726.2M
Q3 25
$2.2B
$653.7M
Q2 25
$1.3B
$688.2M
Q1 25
$1.3B
$743.0M
Q4 24
$1.1B
$823.2M
Q3 24
$591.0M
$669.3M
Q2 24
$668.2M
$688.4M
Q1 24
$750.0M
$737.8M
Debt / Equity
LEU
LEU
SDGR
SDGR
Q4 25
1.54×
Q3 25
3.23×
Q2 25
1.09×
Q1 25
1.82×
Q4 24
2.93×
Q3 24
1.09×
Q2 24
1.13×
Q1 24
2.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LEU
LEU
SDGR
SDGR
Operating Cash FlowLast quarter
$-48.4M
$-16.1M
Free Cash FlowOCF − Capex
$-58.0M
$-16.1M
FCF MarginFCF / Revenue
-39.7%
-18.5%
Capex IntensityCapex / Revenue
6.6%
0.0%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$31.3M
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LEU
LEU
SDGR
SDGR
Q4 25
$-48.4M
$-16.1M
Q3 25
$10.1M
$-61.9M
Q2 25
$52.8M
$-52.2M
Q1 25
$36.5M
$144.1M
Q4 24
$57.9M
$-31.1M
Q3 24
$-33.2M
$-33.3M
Q2 24
$7.0M
$-53.7M
Q1 24
$5.3M
$-39.3M
Free Cash Flow
LEU
LEU
SDGR
SDGR
Q4 25
$-58.0M
$-16.1M
Q3 25
$5.7M
$-62.4M
Q2 25
$49.2M
$-52.5M
Q1 25
$34.4M
$143.5M
Q4 24
$57.2M
$-32.0M
Q3 24
$-34.2M
$-34.6M
Q2 24
$6.1M
$-54.7M
Q1 24
$3.8M
$-43.4M
FCF Margin
LEU
LEU
SDGR
SDGR
Q4 25
-39.7%
-18.5%
Q3 25
7.6%
-114.8%
Q2 25
31.8%
-95.9%
Q1 25
47.1%
240.9%
Q4 24
37.7%
-36.2%
Q3 24
-59.3%
-98.0%
Q2 24
3.2%
-115.6%
Q1 24
8.7%
-118.5%
Capex Intensity
LEU
LEU
SDGR
SDGR
Q4 25
6.6%
0.0%
Q3 25
5.9%
0.9%
Q2 25
2.3%
0.6%
Q1 25
2.9%
1.0%
Q4 24
0.5%
1.0%
Q3 24
1.7%
3.8%
Q2 24
0.5%
2.1%
Q1 24
3.4%
11.2%
Cash Conversion
LEU
LEU
SDGR
SDGR
Q4 25
-0.50×
Q3 25
2.59×
Q2 25
1.83×
Q1 25
1.34×
Q4 24
Q3 24
Q2 24
0.23×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LEU
LEU

Separative Work Units$111.0M76%
Services$21.8M15%
Other$13.4M9%

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons